Inotiv Inc (NOTV)
1.93
-0.21
(-9.81%)
USD |
NASDAQ |
May 17, 16:00
1.935
0.00 (0.00%)
After-Hours: 20:00
Inotiv Enterprise Value: 407.12M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 407.12M |
| May 16, 2024 | 412.53M |
| May 15, 2024 | 415.11M |
| May 14, 2024 | 412.02M |
| May 13, 2024 | 464.89M |
| May 10, 2024 | 454.31M |
| May 09, 2024 | 464.63M |
| May 08, 2024 | 479.85M |
| May 07, 2024 | 478.82M |
| May 06, 2024 | 480.36M |
| May 03, 2024 | 467.47M |
| May 02, 2024 | 464.63M |
| May 01, 2024 | 458.44M |
| April 30, 2024 | 456.38M |
| April 29, 2024 | 453.80M |
| April 26, 2024 | 461.79M |
| April 25, 2024 | 467.98M |
| April 24, 2024 | 477.78M |
| April 23, 2024 | 482.43M |
| April 22, 2024 | 471.34M |
| April 19, 2024 | 468.76M |
| April 18, 2024 | 478.56M |
| April 17, 2024 | 497.13M |
| April 16, 2024 | 502.28M |
| April 15, 2024 | 502.54M |
| Date | Value |
|---|---|
| April 12, 2024 | 511.05M |
| April 11, 2024 | 527.30M |
| April 10, 2024 | 540.97M |
| April 09, 2024 | 547.93M |
| April 08, 2024 | 546.39M |
| April 05, 2024 | 541.49M |
| April 04, 2024 | 542.78M |
| April 03, 2024 | 601.32M |
| April 02, 2024 | 602.09M |
| April 01, 2024 | 611.90M |
| March 28, 2024 | 639.49M |
| March 27, 2024 | 632.01M |
| March 26, 2024 | 616.28M |
| March 25, 2024 | 642.07M |
| March 22, 2024 | 631.75M |
| March 21, 2024 | 615.25M |
| March 20, 2024 | 605.45M |
| March 19, 2024 | 590.49M |
| March 18, 2024 | 588.17M |
| March 15, 2024 | 592.81M |
| March 14, 2024 | 570.63M |
| March 13, 2024 | 570.89M |
| March 12, 2024 | 573.72M |
| March 11, 2024 | 554.12M |
| March 08, 2024 | 575.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
29.88M
Minimum
Jun 17 2019
1.426B
Maximum
Nov 19 2021
411.72M
Average
444.26M
Median
Jan 25 2024
Enterprise Value Benchmarks
| Biolase Inc | 15.13M |
| Akoya Biosciences Inc | 154.64M |
| Durect Corp | 22.04M |
| Macrogenics Inc | 89.16M |
| Candel Therapeutics Inc | 336.07M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.39M |
| Revenue (Quarterly) | 135.50M |
| Total Expenses (Quarterly) | 143.77M |
| EPS Diluted (Quarterly) | -0.60 |
| Gross Profit Margin (Quarterly) | 24.70% |
| Profit Margin (Quarterly) | -11.36% |
| Earnings Yield | -67.36% |
| Operating Earnings Yield | 10.98% |
| Normalized Earnings Yield | -58.19 |